US Broker Ratings

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating a 5.99% Upside in CNS Treatments

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector, is making waves with its focus on developing and commercializing treatments for central nervous..

LifeStance Health Group, Inc. (LFST): Investor Outlook Reveals 84% Potential Upside

For investors seeking opportunities in the healthcare sector, LifeStance Health Group, Inc. (LFST) presents a compelling case with its strong growth potential and expanding reach in..

Recursion Pharmaceuticals (RXRX) Investor Outlook: Biotechnology Innovator with 22.87% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a pioneering entity in the biotechnology sector, is capturing investor attention with its innovative approach to drug discovery and a notable..

Celldex Therapeutics (CLDX) Stock Analysis: Unpacking the 192% Potential Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a cutting-edge biopharmaceutical company headquartered in Hampton, New Jersey, is capturing the attention of investors with its innovative approach to treating..

Adaptive Biotechnologies (ADPT) Stock Analysis: Exploring a 15% Upside Amid Strong Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands at the forefront of innovation in the biotechnology sector, leveraging its immune medicine platform to revolutionize disease diagnosis and treatment...

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating a 34.59% Potential Upside in Healthcare Innovation

Teladoc Health, Inc. (NYSE: TDOC), a pioneer in the virtual healthcare space, is navigating challenging waters with its market capitalization currently standing at a modest $1.2..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: Unveiling a 37.49% Potential Upside

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) is capturing attention in the healthcare sector with a potential upside of 37.49%, according to analyst ratings. As a provider..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Biotech Innovator with 216% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is positioning itself as a compelling player in the biotechnology sector, particularly for investors with an appetite for growth and innovation...

Kestra Medical Technologies (KMTS): Analyst Consensus Highlights an 83% Upside Potential in the Medical Wearables Market

Kestra Medical Technologies, Ltd. (KMTS), an innovative player in the medical instruments & supplies sector, is capturing significant attention with its cutting-edge wearable medical devices. Based..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Unveiling a Potential 103.99% Upside with Innovative Therapeutics

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is gaining attention in the healthcare sector with its innovative approach to treating rare diseases. Based in Durham, North Carolina, BioCryst..

Phreesia, Inc. (PHR) Stock Analysis: Exploring a Promising 18.74% Upside in the Healthcare SaaS Market

Phreesia, Inc. (PHR), a key player in the healthcare information services sector, is generating buzz among investors with its strong growth potential and a notable 18.74%..

Premier, Inc. (PINC) Stock Analysis: Navigating the Healthcare Sector with a 3.60% Dividend Yield

Premier, Inc. (NASDAQ: PINC) stands as a noteworthy player in the healthcare sector, specializing in health information services within the United States. With a market capitalization..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 69% Upside Potential

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, has been attracting investor attention with..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Biotech Contender with a 212% Upside Potential

Dyne Therapeutics, Inc. (NASDAQ: DYN), an emerging player in the biotech sector, is capturing investor attention with its promising therapeutic pipeline and substantial upside potential. With..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Investors Eye a Potential 133.77% Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) is capturing the attention of investors with its promising pipeline in the biotechnology sector, primarily targeting metabolic and endocrine disorders. The..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 60% Potential Upside in the Healthcare Sector

Ardent Health, Inc. (ARDT), a prominent player in the healthcare sector, is catching investor attention with a notable 60.07% potential upside, according to recent analyst ratings...

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 17.94% Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), a key player in the healthcare sector, operates within the medical instruments and supplies industry, delivering innovative solutions in biological and chemical..

Mesoblast Limited (MESO)

⚠️ No article content returned.

..

Select Medical Holdings Corp (SEM) Stock Analysis: Navigating a 47.75% Potential Upside in Healthcare

Select Medical Holdings Corp (SEM), a prominent player in the healthcare sector, offers investors an intriguing opportunity with a significant potential upside of 47.75%. With a..

Perrigo Company plc (PRGO) Stock Analysis: A 55% Potential Upside Beckons Investors in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO) is a notable player in the healthcare sector, specifically in the niche of specialty and generic drug manufacturing. Headquartered in Dublin,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds